IRS Releases Final Rules On Branded Prescription Drug Fee
The Internal Revenue Service published final regulations Monday establishing how branded prescription drug manufacturers or importers who have at least $5 million in sales to various government programs like Medicaid and...To view the full article, register now.
Already a subscriber? Click here to view full article